Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis

Clinical Nephrology

Volumn 60, Issue 1, 2003, Pages 1-6

  Gillerot, G ^a   Devuyst, O ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

Aquaporin 1; Carbonyls; Glucose degradation products; Growth factors; Niric oxide; Nitric oxide synthase; Permeability; Ultrafiltration

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBONYL DERIVATIVE; CYTOKINE; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; GROWTH FACTOR; MATRIX PROTEIN; NITRIC OXIDE; PERITONEAL DIALYSIS FLUID;

ANGIOGENESIS; CELL PROLIFERATION; CYTOKINE PRODUCTION; DIALYSATE; EXPOSURE; FIBROSIS; GLUCOSE ABSORPTION; HUMAN; HYPERGLYCEMIA; LEUKOCYTE ACTIVATION; MESOTHELIUM; MOLECULAR SIZE; MONOCYTE; OSMOSIS; PATHOGENESIS; PERITONEAL DIALYSIS; PERITONEUM; PERMEABILITY; PLASMA; PROTEIN SECRETION; REVIEW; SOLUTE; ULTRAFILTRATION; UREMIA; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0038721302     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp60001     Document Type: Review

References (44)

1. Bikfalvi A, Klein S, Pintucci G, Rifkin DB 1997 Biological roles of fibroblast growth factor-2. Endocrine Rev 18: 26-45
2. Bredt DS, Snyder SH 1994 Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63: 175-195
3. Churchill DN, Thorpe KE, Nolph AD, Keshaviah PR, Oreopoulos DG, Page D 1998 Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9: 1285-1292
4. Combet S, Ferrier ML, Van Landschoot M, Stoenoiu M, Moulin P, Miyata T, Lameire N, Devuyst O 2001 Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications of the peritoneum. J Am Soc Nephrol 12: 2146-2157
5. Combet S, Miyata T, Moulin P, Pouthier D, Goffin E, Devuyst O 2000 Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 11: 717-728
6. Combet S, Van Landschoot M, Moulin P, Piech A, Verbavatz JM, Goffin E, Balligand JL, Lameire N, Devuyst O 1999. Regulation of aquaporin-1 and nitric oxyde synthase isoforms in a rat model of acute peritonitis. J Am Soc Nephrol 10: 2185-2196
7. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI 1998 What really happens to people on long-term peritoneal dialysis? Kidney Int 54: 2207-2217
8. Davies SJ, Phillips L, Naish PF, Russell GI 2001 Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12: 1046-1051
9. De Vriese AS, Tilton RG, Stephan CC, Lameire NH 2001 Vascular endothelial growth factor is essential for hyperglycemia-induced functional and structural alterations of peritoneal membrane. J Am Soc Nephrol 12: 1734-1741
10. Devuyst O, Combet S, Balligand JL, Goffin E, Verbavatz JM 2000 Expression and regulation of aquaporin-1 and endothelial nitric oxide synthase in relationship with water permeability across the peritoneum. In: Hohman S, Nielsen S (eds) Molecular Biology and Physiology of Water and Solute Transport 2000. Kluwer Academic Plenum Publishers, New York, pp 69-75
11. Dobbie JW 1990 New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis 15: 97-109
12. Ferrier ML, Combet S, van Landschoot M, Stoenoiu MS, Cnops Y, Lameire N, Devuyst O 2001 Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis. Kidney Int 60: 2343-2350
13. Ferrara N 1999 Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56: 794-814
14. Flessner M 1999 Changes in the peritoneal interstitium and their effect on peritoneal transport. Perit Dial Int 19: S77-S82
15. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK 2001 Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98: 2604-2609
16. Goffin E, Combet S, Jamar F, Cosyns JP, Devuyst O 1999 Expression of aquaporin-1 (AQP1) in a long-term peritoneal dialysis patient with impaired transcellular water transport. Am J Kidney Dis 33: 383-388
17. Goffin E, van Ypersele de Strihou C 1998 Intractable dehydration in a patient on CAPD. Pathophysiological implications for the classification of peritoneal membrane alterations. Nephrol Dial Transplant 13: 1277-1280
18. Griffioen AW, Molema G 2000 Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52: 237-268
19. Hobbs AJ, Higgs A, Moncada S 1999 Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39: 191-220
20. Honda K, Nitta K, Horita S, Yumura W, Nihei H 1996 Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72: 171-176
21. Hood JD, Meininger CJ, Ziche M, Granger HJ 1998 VEGF upregulates eNOS message, protein, and NO production in human endothelial cells. Am J Physiol 274: H1054-H1058
22. Inagi R, Miyata T, Yamamoto T, Suzuki D, Urakami K, Saito A, van Ypersele de Strihou C, Kurokawa K 1999 Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 463: 260-264
23. Jones S, Holmes CJ, Mackenzie RK, Stead R, Coles GA, Williams JD, Faict D, Topley N 2002 Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol 13 (Suppl 1): S97-103
24. Krediet RT 1999 The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 55: 341-356
25. Krediet RT, van Westrhenen R, Zweers MM, Struijk DG 2002 Clinical advantages of new peritoneal dialysis solutions. Nephrol Dial Transplant 17 (Suppl 3): 16-18
26. Kubes P 1995 Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2: 235-244
27. Lamb EJ, Worrall J, Buhler R, Harwood S, Cattell WR, Dawnay AB 1995 Effect of diabetes and peritonitis on the peritoneal equilibration test. Kidney Int 47: 1760-1767
28. Margetts PJ, Gyorffy S, Kolb M, Yu L, Hoff CM, Holmes CJ, Gauldie J 2002 Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13: 721-772
29. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, Krediet RT 1999 Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19: 517-525
30. Miyata T, Devuyst O, Kurokawa K, van Ypersele de Strihou C 2002 Advances in the biochemistry and pathophysiology of the peritoneal membrane: new therapeutic insights into more biocompatible peritoneal dialysis. Kidney Int 61: 375-386
31. Miyata T, Kurokawa K, van Ypersele de Strihou C 2000 Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 11: 1744-1752
32. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW 1999 Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55: 389-399
33. Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH 2002 Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 13: 480-489
34. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z 1999 Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22
35. Pecoits-Filho R, Araujo MR, Lindholm B, Stenvinkel P, Abensur H, Romao JE Jr, Marcondes M, De Oliveira AH, Noronha IL 2002 Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17: 1480-1486
36. Rippe B, Simonsen O, Heimburger O, Christensson A, Haraldsson B, Stelin G, Weiss L, Nielsen FD, Bro S, Friedberg M, Wieslander A 2001 Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 59: 348-357
37. Rippe B, Stelin G, Haraldsson B 1991 Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 40: 315-325
38. Rubin J, Rust P, Brown P, Popovich RP, Nolph KD 1981 A comparison of peritoneal transport in patients with psoriasis and uremia. Nephron 29: 185-189
39. Selgas R, Bajo MA, Castro MJ, del Peso G, Aguilera A, Fernandez-Perpen A, Cirugeda A, Sanchez-Tomero JA 2000 Risk factors responsible for ultrafiltration failure in early stages of peritoneal dialysis. Perit Dial Int 20: 631-636
40. Stoenoiu MS, De Vriese AS, Brouet A, Moulin P, Feron O, Lameire N, Devuyst O 2002 Experimental diabetes induces functional and structural changes in the peritoneum. Kidney Int 62: 668-678
41. Stoenoiu MS, Ni J, Verkaeren C, Debaix H, Jonas J-C, Lameire N, Verbavatz J-M, Devuyst O 2003 Corticosteroids induce expression of aquaporin-1 and increase transcellular water transport in rat peritoneum. J Am Soc Nephrol 14: 555-565
42. Ueda Y, Miyata T, Goffin E, Yoshino A, Inagi R, Ishibashi Y, Izuhara Y, Saito A, Kurokawa K, van Ypersele de Strihou C 2000 Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids. Kidney Int 58: 2518-2524
43. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT, Peritoneal Biopsy Study Group 2002 Peritoneal biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13: 470-479
44. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jorres A 2001 Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 12: 2434-2441